September 9, 2014 — Accuray Inc. announced it has been awarded a new exclusive three-year group purchasing agreement with Premier Inc., covering the CyberKnife M6 and TomoTherapy HDA product portfolios. The Accuray and Premier partnership brings together two companies committed to driving improved patient care through meaningful technical innovation.
"Our goal is to help healthcare providers offer the best treatment option for their patients. The Premier agreement is important because it enables us to partner with a large sales force that has long-standing relationships with hospital-based clinicians and administrators to significantly increase visibility of the CyberKnife and TomoTherapy systems," said Kelly Londy, executive vice president and chief commercial officer of Accuray.
Premier has one of the nation's largest group purchasing organizations (GPOs). Under the new contract, Accuray's precise, clinically proven tumor treatments became available starting Sept. 1 to Premier member hospitals and providers. Premier unites an collective of more than 3,000 hospitals and 110,000 other providers, including oncology centers. In addition, the contract provides Accuray with access to key Premier integrated delivery network partners, where Accuray has had limited historical business presence.
"We believe the Premier agreement will provide improved deal visibility to radiation equipment purchasing decisions earlier in the process and, ultimately, result in new opportunities for Accuray equipment and services," said Joshua H. Levine, president and CEO of Accuray. "The partnership also validates our focus on service excellence and technology performance, and demonstrates the confidence the radiation oncology community has in the unique benefits of the CyberKnife and TomoTherapy Systems."
For more information: www.accuray.com
April 21, 2025 
